Clinical, laboratory and health-related quality of life correlates of Systemic Lupus Erythematosus Responder Index response: a post hoc analysis of the phase 3 belimumab trials

医学 贝里穆马布 析因分析 系统性红斑狼疮 内科学 红斑狼疮 临床试验 生活质量(医疗保健) 布利西比莫德 疾病 胃肠病学 免疫学 抗体 护理部 B细胞 B细胞激活因子
作者
Richard Furie,Michelle Petri,Vibeke Strand,Dafna D. Gladman,Z. John Zhong,William W. Freimuth,Bliss Study Groups
出处
期刊:Lupus science & medicine [BMJ]
卷期号:1 (1): e000031-e000031 被引量:61
标识
DOI:10.1136/lupus-2014-000031
摘要

Objective

Correlates of systemic lupus erythematosus (SLE) Responder Index (SRI) response with clinical trial end points were examined using pooled data from the Study of Belimumab in Subjects with SLE (BLISS) trials (N=1684).

Methods

Changes in clinical, laboratory and health-related quality of life measures from baseline at 52 weeks were compared between SRI responders (n=761) and non-responders (n=923).

Results

More SRI responders than non-responders had ≥4-point (100% vs 3.8%) and ≥7-point (40.3% vs 1.3%) Safety of Estrogens in Lupus Erythematosus National Assessment-Systemic Lupus Erythematosus Disease Activity Index reductions, no new British Isles Lupus Assessment Group (BILAG) A and ≤1 new B scores (91.9% vs 35.9%), and a 25% reduction in corticosteroid dose decrease of 25% from >7.5 mg/d to ≤7.5 mg/d (25.5% vs 13.9%), and fewer had a corticosteroid increase from ≤7.5 mg/d to >7.5 mg/d (4.1% vs 21.3%; all p<0.001). More responders than non-responders had improved organ domains: Safety of Estrogens in Lupus Erythematosus National Assessment-Systemic Lupus Erythematosus Disease Activity Index (mean 1.45 vs 0.40), BILAG (2.00 vs 0.39), and greater improvement in Physician9s Global Assessment (all p<0.001). Risks for developing any SLE flare or severe flare were reduced in responders by 42% and 87%, respectively (p<0.001). Responders reported greater improvements in Medical Outcomes Survey Short Form version 2 Physical and Mental Components and all domain scores, and Functional Assessment of Chronic Illness Therapy-Fatigue score compared with non-responders (all p<0.001).

Conclusion

Overall, SRI response in patients with active, autoantibody-positive SLE was associated with improvements in clinical, laboratory and patient-reported outcome measures, indicating that SRI response was associated with a global benefit.

Trial registration number

NCT00424476; NCT00410384.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
雨柏完成签到 ,获得积分10
1秒前
wanci应助qwe1108采纳,获得10
2秒前
明天过后完成签到,获得积分10
4秒前
jin完成签到,获得积分10
5秒前
yhy完成签到 ,获得积分10
6秒前
黑色卡布奇诺完成签到,获得积分20
6秒前
tanglu发布了新的文献求助10
6秒前
可爱的函函应助梁大海采纳,获得10
6秒前
成就绮琴完成签到 ,获得积分10
7秒前
xicifish完成签到,获得积分10
7秒前
目光之澄完成签到,获得积分10
8秒前
wanci应助研友_ndDPBn采纳,获得10
8秒前
耍酷的白梦完成签到,获得积分10
9秒前
miracle完成签到 ,获得积分10
10秒前
coding完成签到,获得积分10
11秒前
12秒前
犹豫水蓝完成签到,获得积分10
13秒前
yin完成签到,获得积分10
13秒前
JUGG完成签到,获得积分10
13秒前
CipherSage应助阿湫采纳,获得10
14秒前
FIN应助手机采纳,获得20
14秒前
星辰大海应助东黎采纳,获得10
14秒前
量子星尘发布了新的文献求助10
14秒前
wujingshuai完成签到,获得积分10
15秒前
少年完成签到,获得积分10
15秒前
星辰大海应助ficus_min采纳,获得10
16秒前
小柒柒完成签到,获得积分10
17秒前
sdfwsdfsd完成签到,获得积分10
18秒前
亮仔完成签到,获得积分10
19秒前
土豆丝发布了新的文献求助10
19秒前
ylw完成签到,获得积分20
20秒前
西门明雪完成签到,获得积分10
20秒前
20秒前
烟花应助万松辉采纳,获得10
21秒前
爆米花应助不站在雾里采纳,获得10
21秒前
yy完成签到,获得积分20
22秒前
高贵宛海完成签到,获得积分10
22秒前
854fycchjh完成签到,获得积分10
23秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038524
求助须知:如何正确求助?哪些是违规求助? 3576221
关于积分的说明 11374737
捐赠科研通 3305912
什么是DOI,文献DOI怎么找? 1819354
邀请新用户注册赠送积分活动 892688
科研通“疑难数据库(出版商)”最低求助积分说明 815048